These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9488612)

  • 1. Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group.
    Paietta E; Andersen J; Yunis J; Rowe JM; Cassileth PA; Tallman MS; Bennett JM; Wiernik PH
    Br J Haematol; 1998 Feb; 100(2):265-72. PubMed ID: 9488612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials.
    Paietta E; Neuberg D; Bennett JM; Dewald G; Rowe JM; Cassileth PA; Cripe L; Tallman MS; Wiernik PH;
    Leukemia; 2003 Aug; 17(8):1544-50. PubMed ID: 12886241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of membrane CD11b, CD11c and CD14 expression in acute myeloid leukaemia: relationships with monocytic subtypes and the concept of relative antigen expression.
    Scott CS; Richards SJ; Master PS; Kendall J; Limbert HJ; Roberts BE
    Eur J Haematol; 1990 Jan; 44(1):24-9. PubMed ID: 1689668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
    Paietta E; Van Ness B; Bennett J; Racevskis J; Gucalp R; Cassileth P; Wiernik PH
    Br J Haematol; 1992 Oct; 82(2):324-31. PubMed ID: 1419814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
    Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
    Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia.
    Tisone JA; Bohman JE; Theil KS; Brandt JT
    Am J Clin Pathol; 1997 Mar; 107(3):283-91. PubMed ID: 9052378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.
    Muñoz L; Aventín A; Villamor N; Juncà J; Acebedo G; Domingo A; Rozman M; Torres JP; Tormo M; Nomdedéu JF
    Haematologica; 2003 Jun; 88(6):637-45. PubMed ID: 12801839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission.
    Whiteway A; Corbett T; Anderson R; Macdonald I; Prentice HG
    Br J Haematol; 2003 Feb; 120(3):442-51. PubMed ID: 12580958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD117/CD34 expression in leukemic blasts.
    Wells SJ; Bray RA; Stempora LL; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
    Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
    Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
    Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
    Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
    Tallman MS; Kim HT; Paietta E; Bennett JM; Dewald G; Cassileth PA; Wiernik PH; Rowe JM;
    J Clin Oncol; 2004 Apr; 22(7):1276-86. PubMed ID: 14970186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of P-selectin glycoprotein ligand-1 as a useful marker in acute myeloid leukaemias.
    Kappelmayer J; Kiss A; Karászi E; Veszprémi A; Jakó J; Kiss C
    Br J Haematol; 2001 Dec; 115(4):903-9. PubMed ID: 11843824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.